CD47 Blockade and Cowpea Mosaic Virus Nanoparticle In Situ Vaccination Triggers Phagocytosis and Tumor Killing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD47 Blockade and Cowpea Mosaic Virus Nanoparticle In Situ Vaccination Triggers Phagocytosis and Tumor Killing

Published:2019-03-06 Issue:8 Volume:8 Page:1801288
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Wang Chao¹²^ORCID,Steinmetz Nicole F.¹²³^ORCID

Affiliation:

1. Department of NanoEngineeringUniversity of California San Diego, La Jolla CA 92093 USA

2. Department of Biomedical EngineeringCase Western Reserve University School of Medicine Cleveland OH 44106 USA

3. Department of RadiologyMoores Cancer CenterDepartment of BioengineeringUniversity of California San Diego, La Jolla CA 92093 USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.201801288

Reference44 articles.

1. Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with previously treated, recurrent or refractory ovarian cancer: A phase Ib, open-label expansion trial.

2. Antitumor activity and safety of pembrolizumab in patients (pts) with PD-L1 positive advanced ovarian cancer: Interim results from a phase Ib study.

3. Cancer immunotherapy targeting the CD47/SIRPα axis

4. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

5. Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted cancer alleviation by cowpea mosaic virus in a bioprinted ovarian cancer peritoneal spheroid model;Biomaterials;2024-12

2. Advancing Scaffold‐Assisted Modality for In Situ Osteochondral Regeneration: A Shift From Biodegradable to Bioadaptable;Advanced Materials;2024-08-06

3. Enhancing in situ cancer vaccines using delivery technologies;Nature Reviews Drug Discovery;2024-07-01

4. SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer;Immunologic Research;2024-06-18

5. The biological roles of CD47 in ovarian cancer progression;Cancer Immunology, Immunotherapy;2024-06-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3